Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health operating margin
Operating margin is operating income as a percentage of revenue.
Evolent Health's operating margin for the twelve months ending Sep 30, 2026 was -18.5%. For fiscal 2025 it was -21.9%, against -1.6% the year before. The highest annual figure on record is 0.3% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21.9% | −20.3 |
| FY2024 | Dec 31, 2024 | -1.6% | +2.0 |
| FY2023 | Dec 31, 2023 | -3.6% | −3.9 |
| FY2022 | Dec 31, 2022 | 0.3% | +4.9 |
| FY2021 | Dec 31, 2021 | -4.7% | +23.8 |
| FY2020 | Dec 31, 2020 | -28.4% | +16.5 |
| FY2019 | Dec 31, 2019 | -45.0% | −37.4 |
| FY2018 | Dec 31, 2018 | -7.6% | +9.2 |
| FY2017 | Dec 31, 2017 | -16.7% | +76.7 |
| FY2016 | Dec 31, 2016 | -93.4% | −49.0 |
| FY2015 | Dec 31, 2015 | -44.4% | +38.1 |
| FY2013 | Dec 31, 2013 | -82.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -0.9% | −1.0 |
| Q2 FY2026 | Jun 30, 2026 | -1.5% | −1.2 |
| Q1 FY2026 | Mar 31, 2026 | -2.1% | −1.8 |
| Q4 FY2025 | Dec 31, 2025 | -87.1% | −84.2 |
| Q3 FY2025 | Sep 30, 2025 | 0.2% | +2.8 |
| Q2 FY2025 | Jun 30, 2025 | -0.3% | −1.5 |
| Q1 FY2025 | Mar 31, 2025 | -0.3% | +1.8 |
| Q4 FY2024 | Dec 31, 2024 | -2.9% | +1.0 |
| Q3 FY2024 | Sep 30, 2024 | -2.6% | +0.9 |
| Q2 FY2024 | Jun 30, 2024 | 1.2% | +5.8 |
| Q1 FY2024 | Mar 31, 2024 | -2.1% | +0.3 |
| Q4 FY2023 | Dec 31, 2023 | -3.8% | −3.3 |
| Q3 FY2023 | Sep 30, 2023 | -3.5% | −7.2 |
| Q2 FY2023 | Jun 30, 2023 | -4.6% | −3.1 |
| Q1 FY2023 | Mar 31, 2023 | -2.4% | −1.5 |
| Q4 FY2022 | Dec 31, 2022 | -0.5% | +4.4 |
| Q3 FY2022 | Sep 30, 2022 | 3.7% | +6.6 |
| Q2 FY2022 | Jun 30, 2022 | -1.4% | +2.0 |
| Q1 FY2022 | Mar 31, 2022 | -0.9% | +6.5 |
| Q4 FY2021 | Dec 31, 2021 | -4.9% | −6.8 |
| Q3 FY2021 | Sep 30, 2021 | -3.0% | +3.9 |
| Q2 FY2021 | Jun 30, 2021 | -3.5% | +100.5 |
| Q1 FY2021 | Mar 31, 2021 | -7.4% | +3.9 |
| Q4 FY2020 | Dec 31, 2020 | 1.8% | +93.5 |
| Q3 FY2020 | Sep 30, 2020 | -6.9% | +2.3 |
| Q2 FY2020 | Jun 30, 2020 | -103.9% | −90.8 |
| Q1 FY2020 | Mar 31, 2020 | -11.3% | +12.2 |
| Q4 FY2019 | Dec 31, 2019 | -91.7% | −84.8 |
| Q3 FY2019 | Sep 30, 2019 | -9.1% | −1.8 |
| Q2 FY2019 | Jun 30, 2019 | -13.1% | −6.9 |
| Q1 FY2019 | Mar 31, 2019 | -23.6% | −13.5 |
| Q4 FY2018 | Dec 31, 2018 | -6.9% | +9.1 |
| Q3 FY2018 | Sep 30, 2018 | -7.4% | +5.6 |
| Q2 FY2018 | Jun 30, 2018 | -6.2% | +11.6 |
| Q1 FY2018 | Mar 31, 2018 | -10.1% | +10.1 |
| Q4 FY2017 | Dec 31, 2017 | -16.0% | +22.4 |
| Q3 FY2017 | Sep 30, 2017 | -13.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -17.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -20.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -38.5% | – |
See a number that looks wrong?